Global Fatty Liver Treatment Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Fatty Liver Treatment Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market size for fatty liver treatment has shown significant expansion in recent years. It is forecast to increase from $23.73 billion in 2024 to $25.05 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%. The growth observed in previous periods is attributable to the obesity epidemic, sedentary lifestyles, unhealthy diets, limited treatment options, and awareness campaigns.

The fatty liver treatment market is projected to experience substantial growth over the next few years. It is forecast to expand to $32.98 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is driven by an increase in disease prevalence, escalating healthcare expenditure, the rising incidence of diabetes and metabolic syndrome, and therapeutic innovations. Significant trends expected during this period include precision medicine approaches, lifestyle modification programs, targeted therapies for Nash, non-invasive monitoring tools, and technological advancements.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

Which Drivers Are Supporting Growth Of The Fatty Liver Treatment Market?

The rising intake of alcohol is anticipated to boost the expansion of the fatty liver treatment market in the future. Alcohol consumption denotes the intake of drinks that contain alcohol, which is a psychoactive compound having a depressive impact on the central nervous system. The consumption of alcohol has the potential to aggravate fatty liver disease and progress to more serious hepatic conditions, such as alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. As an illustration, in March 2023, data from the HRB National Drugs Library, an Ireland-based government-funded organization, indicated that in 2022, alcohol consumption in Scotland climbed to 10.2 liters of pure alcohol per capita for individuals over the age of 15. This represented a 7.6% rise compared to 2021, underscoring a worrying increasing pattern in alcohol intake despite continuous public health initiatives aimed at curbing consumption. Consequently, the escalation in alcohol consumption is fueling the expansion of the fatty liver treatment market.

What Are The Leading Segments Analyzed In The Fatty Liver Treatment Market?

The fatty liver treatmentmarket covered in this report is segmented –

1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants; Chemotherapy Drugs; Targeted Therapy; Vaccines; Anti-Viral Drugs

2) By Disease Type: Hepatitis; Liver Cancer; Non-Alcoholic Fatty Liver Disease; Other Diseases

3) By End User: Hospitals; Ambulatory Surgery Centers; Other End Users

Subsegments:

1) By Anti-Rejection Drugs Or Immunosuppressants: Corticosteroids; Calcineurin Inhibitors; mTOR Inhibitors

2) By Chemotherapy Drugs: Conventional Chemotherapy Agents; Novel Chemotherapeutics Under Investigation

3) By Targeted Therapy: Small Molecule Inhibitors; Monoclonal Antibodies

4) By Vaccines: Therapeutic Vaccines; Preventive Vaccines

5) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs); Nucleos(t)ide Analogs

What Trends Are Redefining The Fatty Liver Treatment Market Dynamics?

Product innovation represents a key trend that is growing in prominence within the fatty liver treatment market. Major companies involved in fatty liver treatment are creating new products to solidify their market position. For example, in March 2023, Akero Therapeutics, a US-based biotechnology company, disclosed positive Phase II reports concerning efruxifermin, a drug indicated for addressing non-invasively diagnosed nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). This compound is a distinctive Fc-FGF21 fusion protein that emulates the biological activity of fibroblast growth factor 21 (FGF21), which regulates a variety of metabolic pathways and cellular processes.

Who Are The Key Multinational Companies Dominating The Fatty Liver Treatment Market?

Major companies operating in the fatty liver treatment market include Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithkline plc, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

What Regional Growth Trends Are Shaping The Fatty Liver Treatment Market Outlook?

North America was the largest region in the fatty liver treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Fatty Liver Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12581&type=smp

Browse Through More Reports Similar to the Global Fatty Liver Treatment Market 2025, By The Business Research Company

Liver Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Fatty Amines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fatty-amines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795